The report “Single-Use Assemblies Market by Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly), Application (Filtration, Storage), Solution (Standard, Customized), End User (Pharmaceutical Companies, CMOs and CROs) – Global Forecast to 2024″, is expected to grow from USD 805 million in 2019 to USD 1,825 million by 2024, at a CAGR of 16.5% during the forecast period.

Growth Driver: Rapid implementation and low risk of cross-contamination;

A single-use solution has numerous advantages over traditional bioprocessing technologies, due to which the adoption of single-use assemblies is growing continuously. These include the faster implementation of single-use assembly components in the bioprocess cycle and a lower risk of cross-contamination. Single-use assemblies are ergonomically designed to hold integrated single-use flow paths for faster set-up and reduced space requirements. The product design is aimed to reduce the amount of time and cost related to preparation, set-up, testing, validation, and documentation. In addition, with the elimination of the Clean-In-Place (CIP) and Sterilization-In-Place (SIP) steps, the project lead time for the implementation of single-use production plants is reduced by at least eight months as compared to stainless-steel reactors and reusable assemblies. Owing to such advantages, single-use solutions enable faster batch turnaround and product change-over.

Product cross-contamination is a major concern in the biomanufacturing industry. The potential for cross-contamination occurs when the same process equipment is used repeatedly in the process cycle. Unwanted protein contamination, for example, may reduce production yields by requiring additional purification steps, or in the worst possible case, proteins that co-purify may result in potentially fatal treatments. Since the product flow path is discarded and replaced after each batch, the risk of product cross-contamination between batches is virtually eliminated with the use of single-use assembly components. Single-use component manufacturers also typically make and assemble products in cleanrooms to ensure that their products do not introduce harmful particulates and endotoxins into a bioprocess. Such advantages are driving the adoption of single-use assemblies among end users in the biopharmaceutical & pharmaceutical industries.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549

The bag assemblies segment is expected to grow at the highest CAGR during the forecast period

Based on product, is broadly segmented into bag assemblies, filtration assemblies, bottle assemblies, mixing system assemblies, and other products. The bag assembly segment is projected to grow at the highest CAGR during the forecast period as it enables critical liquid handling in bio-manufacturing and eliminate the time & cost of additional cleaning and sterilization, system set-up, maintenance, and validation.

Geographical View in-detailed:

The single-use assemblies market is divided into four major regions-Europe, North America, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the global market, closely followed by Europe. Factors such as the presence of a well-established biopharmaceutical industry in the region has created significant demand for single-use assemblies, low risk of contamination and low implementation costs, their adoption in biopharmaceutical companies for R&D are driving the growth of the market in North America.

Global Key Leaders:

The major companies in the single-use assemblies market include Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher (US), Merck Millipore (Germany)), and GE Healthcare (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46226549

Sartorius Stedim Biotech (France) is the most significant player in the global single-use assemblies market. The company has an expansive range of single-use assemblies products. The growth of revenue is strongly backed up by demand from the Americas and the APAC countries, and efforts of the company strongly rely on meeting with the differentiated needs of consumers from emerging markets. Sartorius Stedim Biotech launched two new products in the past three years, including single-use filter assemblies products in the past three years, including such as Sartocon Self-contained Filter Loop Assembly and Sartocon Slice Self-contained Bag Loop Assembly.

Thermo Fisher Scientific (US) is the second-largest player in the global single-use assemblies market. The company provides a comprehensive portfolio of single-use bio containers, bottle assemblies, filling assemblies, transfer assembly mixers, tubing, connectors, and sensors in the market. The core sales of the company’s single-use assemblies products continued to grow with demand across North America particularly US, and high-growth markets; the company launched several single-use products, including imPULSE and HyPerforma as well as Harvestainer Microcarrier among others.